Daejeon, South Korea

Yeon Chul Kim

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Lg Life Sciences, Limited. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yeon Chul Kim. Retrieved from https://idiyas.com/inventor/yeon-chul-kim-d1quxknq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yeon Chul Kim: Innovator in Hybrid Promoter Technology

Introduction

Yeon Chul Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of hybrid promoters that enhance protein expression in eukaryotic cells. His innovative work has implications for the production of antibodies and DNA vaccines.

Latest Patents

Yeon Chul Kim holds a patent for a hybrid promoter and recombinant vector comprising the same. This invention relates to a hybrid promoter that combines elements from a CMV enhancer, a β-actin promoter, a CMV promoter, and a β-actin intron. The hybrid promoter is designed to induce high expression of target proteins in eukaryotic cells, making it a valuable tool for pharmaceutical applications.

Career Highlights

Throughout his career, Yeon Chul Kim has worked with prominent companies in the biotechnology sector, including LG Life Sciences and LG Chem. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in genetic engineering and molecular biology.

Collaborations

Yeon Chul Kim has collaborated with notable colleagues such as Saem Jung and Jun Jung. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Yeon Chul Kim's contributions to hybrid promoter technology exemplify the impact of innovative thinking in biotechnology. His work not only advances scientific understanding but also paves the way for future developments in medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…